BETH FISZER: Open Payments
NPI 1407329303 · DUNCAN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 49 payments from 18 companies in 2025. Trend: 2023 $981 · 2024 $914 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $149 |
| Abbott Laboratories | 4 | $99 |
| Novo Nordisk Inc | 6 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| PFIZER INC. | 4 | $82 |
| Lilly USA, LLC | 4 | $60 |
| Astellas Pharma US Inc | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $24 |
Products named: FREESTYLE LIBRE 3, FARXIGA, VRAYLAR, NURTEC ODT, Ozempic, Veozah, QULIPTA, MOUNJARO.
Industry payments across SC — which companies pay providers there.
